PB1013 Evaluation of the Diagnostic Performance of Three D-Dimer Assays in Patients with Suspected Deep Vein Thrombosis

ISTH Academy, Faculty / Presenters, 407629

PB1014 The Optimal Cutoff of NT-proBNP for the Risk-Stratification of Hemodynamically Stable Patients with Acute Pulmonary Embolism

ISTH Academy, Faculty / Presenters, 407630

PB1015 Venous Thromboembolism in Patients with Newly Diagnosed Lymphoma and Its Association with ThroLy and Khorana Risk Scores

ISTH Academy, Faculty / Presenters, 407631

PB1010 Exercise Could Reveal Pulmonary Vascular Abnormalities in Patients with Chronic Thromboembolic Pulmonary Disease - A Hemodynamic Study

ISTH Academy, Faculty / Presenters, 407632

PB1011 Research on the Novel Biomarkers of Extracellular Vesicles in the Diagnosis of Post-Traumatic Deep Vein Thrombosis

ISTH Academy, Faculty / Presenters, 407633

PB1007 Diagnostic Yield of Imaging for Pulmonary Embolism by Presenting Complaint in the Emergency Department: An Observational Study

ISTH Academy, Faculty / Presenters, 407634

PB1008 The Diagnostic Performance of the YEARS and PEGeD Algorithm in Patients with Prior Venous Thrombosis Suspected of Pulmonary Embolism

ISTH Academy, Faculty / Presenters, 407635

PB1006 Accuracy and Interrater Agreement of Death Event Adjudications by Physician Trainees: Validation of the ISTH Definition of Pulmonary Embolism-Related Death in an Autopsy Cohort

ISTH Academy, Faculty / Presenters, 407636

PB1470 Prognostic Value of Determination of Genes Mutations in Patients with Pulmonary Thrombembolism - Multicentre Cohort Study

ISTH Academy, Faculty / Presenters, 407637

PB1466 Early Mortality in Pulmonary Embolism - A Systematic Review and Analysis

ISTH Academy, Faculty / Presenters, 407638

PB1467 Hospital-Acquired (HA) versus Post-Discharge (PD) Venous Thromboembolism (VTE) Similarities and Differences: Analysis of the Medical Inpatient Thrombosis and Hemostasis (MITH) Population

ISTH Academy, Faculty / Presenters, 407639

PB1464 Health literacy among Anticoagulated Patients from a Specialized Unit and Its Impact on Treatment

ISTH Academy, Faculty / Presenters, 407640

PB1465 Venous Thromboembolism in Hospitals Belonging to APHP: A Retrospective Cross-Sectional Study Using the Hospital Discharge Database (PMSI) from Clinical Data Warehouse

ISTH Academy, Faculty / Presenters, 407641

PB1463 Clinical Predictors of In-Hospital Mortality in Patients with Acute Pulmonary Embolism: 15-Years Experience in a Single Center in Argentina

ISTH Academy, Faculty / Presenters, 407642

PB1461 Peri-Operative Venous Thromboembolism (VTE) Risk for Below Knee Amputations

ISTH Academy, Faculty / Presenters, 407643

PB1462 The Safety of Anticoagulation in Electroconvulsive Therapy - A Systematic Review

ISTH Academy, Faculty / Presenters, 407644

PB1459 A Decreased Endogenous Thrombin Potential is Associated with Recurrent Venous Thromboembolism

ISTH Academy, Faculty / Presenters, 407645

PB1460 Venous Anomalies - An Under-Recognised but Important Cause of Venous Thromboembolism (VTE)

ISTH Academy, Faculty / Presenters, 407646

PB1457 The Care Pathway of Patients Diagnosed with Venous Thromboembolism in Emergency Departments: A Retrospective Cross-Sectional Study Using the AP-HP Hospitals Warehouse Hospital Discharge Database

ISTH Academy, Faculty / Presenters, 407647

PB1455 Incidence of Recurrence and Bleeding Rates in Isolated Superficial Vein Thrombosis. Findings from the TROLL Registry

ISTH Academy, Faculty / Presenters, 407648

PB1456 The Impact of Heart Rate on the Prediction of Mortality in Patients with Acute Pulmonary Embolism

ISTH Academy, Faculty / Presenters, 407649

PB1453 Clinical Course and Long-Term Outcomes of Cerebral Venous Sinus Thrombosis in Asians

ISTH Academy, Faculty / Presenters, 407650

PB1451 Chronic Inflammatory Diseases Increase the Risk of Recurrent Venous Thromboembolism Irrespective of Anti-Inflammatory Treatment

ISTH Academy, Faculty / Presenters, 407651

PB1452 Hemorrhagic and Thrombotic Complications in Patients Receiving Therapeutic Plasma Exchange

ISTH Academy, Faculty / Presenters, 407652

PB1501 Devising a Neurosciences-Specific Venous Thromboembolism Risk Assessment Method Balancing Thrombotic and Hemorrhagic Risks

ISTH Academy, Faculty / Presenters, 407653

PB1500 In-Hospital Vein Thromboembolism Prevention in Patients with Atrial Fibrillation

ISTH Academy, Faculty / Presenters, 407654

PB1499 Reducing Hospital Acquired Thrombosis in Wales - A National Approach

ISTH Academy, Faculty / Presenters, 407655

PB1498 Risk of Venous Thromboembolic Disease and Adequacy of Prophylaxis in Hospitalized Cancer Patients in Uruguay

ISTH Academy, Faculty / Presenters, 407656

PB1495 Comfort and Experiences Providing Care to Transgender Youth Among Hematologists in the Midwestern United States

ISTH Academy, Faculty / Presenters, 407657

PB1496 Effect of Atorvastatin on NF-κB and D-dimer in High Risk Thrombosis Cancer Patients Undergoing Chemotherapy

ISTH Academy, Faculty / Presenters, 407658

PB1497 Patients Prefer Oral Agents Over Subcutaneous Injections for Thromboprophylaxis following Hip Fracture Surgery

ISTH Academy, Faculty / Presenters, 407659

PB1490 Mesoglycan versus Placebo in Secondary Prevention of Superficial Vein Thrombosis. Rationale and Protocol

ISTH Academy, Faculty / Presenters, 407660

PB1491 Prevention of Venous Thromboembolism after Thermal Methods of Treatment of Lower Extremity Varicose Vein Disease

ISTH Academy, Faculty / Presenters, 407661

PB1489 Clinician and Informaticist Perceptions on the Potential for Artificial Intelligence to Improve Venous Thromboembolism Management

ISTH Academy, Faculty / Presenters, 407662

PB1488 Risk of Venous Thromboembolic Disease and Adequacy of Thromboprophylaxis at a Teaching Hospital and Incidence of VTE in the Three Months after Admission

ISTH Academy, Faculty / Presenters, 407663

PB1485 Patients' Knowledge about Venous Thromboembolism and Oral Anticoagulation Increases the Risk of Clinical Outcomes during Long-Term Follow-up

ISTH Academy, Faculty / Presenters, 407664

PB1486 Quality of Anticoagulation Management in Patients Receiving Warfarin at Private Cardiac Centers in Addis Ababa, Ethiopia

ISTH Academy, Faculty / Presenters, 407665

PB1487 Venous Thromboembolism and Major Bleeding Risk in Hospitalized Obese Patients Receiving Thromboprophylaxis with Enoxaparin

ISTH Academy, Faculty / Presenters, 407666

PB1483 Right Needle, Right Patient, Right Time? A National Flash-Mob Audit of Thromboprophylaxis of Cancer Inpatients Receiving Palliative Care

ISTH Academy, Faculty / Presenters, 407667

PB1484 The Use of Artificial Intelligence for Preventing Venous Thromboembolism in Hospitalized Patients: A National Qualitative Study

ISTH Academy, Faculty / Presenters, 407668

PB1481 Evaluation of the Usage of an Electronic Venous Thromboembolism Assessment Tool for Ambulatory Oncology Patients at a Canadian Community Cancer Centre

ISTH Academy, Faculty / Presenters, 407669

PB1482 Thrombelastography Identifies Persistent Platelet-Mediated Hypercoagulability in Patients with Metastatic Bone Disease Requiring Orthopaedic Surgery

ISTH Academy, Faculty / Presenters, 407670

PB1477 An Early Coagulation Factor Dominant Hypercoagulability is followed by a Prolonged Platelet-Dominant Hypercoagulability in Patients with Hip Fracture

ISTH Academy, Faculty / Presenters, 407671

PB1478 Attributes of Randomized Controlled Trials and Their Associations with Funding Sources in Venous Thromboembolism Prophylaxis for Patients with Cancer: A Bibliographical Analysis

ISTH Academy, Faculty / Presenters, 407672

PB1474 Analysis of Thromboprophylaxis Prescribing Using a Cohort Extraction and Information Retrieval Platform, a UK Experience

ISTH Academy, Faculty / Presenters, 407673

PB1475 Network Meta-Analysis Identifies a Care Gap in Optimizing Thromboprophylaxis Following Hip Fracture Surgery

ISTH Academy, Faculty / Presenters, 407674

PB1476 Occurrence of Hospital-Associated Thrombosis Despite Thromboprophylaxis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study

ISTH Academy, Faculty / Presenters, 407675

PB1471 Age- and Sex Specific Risks of Major Cardiovascular Complications and Death following Elective Hip and Knee Arthroplasty in the Netherlands: A Dutch Hospital Data Registry Study

ISTH Academy, Faculty / Presenters, 407676

PB1472 One-Week versus Extended Antithrombotic Prophylaxis after Laparoscopic Surgery for Colorectal Cancer: An Individual Patient Meta-Analysis

ISTH Academy, Faculty / Presenters, 407677

PB0515 MAC Project—Monitoring Anticoagulant Therapy Observational Study: Rationale and Protocol

ISTH Academy, Faculty / Presenters, 407678

PB0512 Impact of the Pandemic on Anticoagulant Therapy - Preliminary Study

ISTH Academy, Faculty / Presenters, 407679

PB0514 Report of Clinical Case: Glanzmann Thrombasthenia and Vein Thrombosis

ISTH Academy, Faculty / Presenters, 407680

PB0510 Primary Care Clinician Perceptions and Use of Reduced-Dose Direct Oral Anticoagulants for Extended Phase Venous Thromboembolism Treatment

ISTH Academy, Faculty / Presenters, 407681

PB0511 Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure

ISTH Academy, Faculty / Presenters, 407682

PB0506 Clinical Outcomes of Patients Prescribed Apixaban in End Stage Renal Disease Undergoing Dialysis. Results from a Tertiary Centre in UK - A Retrospective Observational Audit

ISTH Academy, Faculty / Presenters, 407683

PB0508 Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients with β-Thalassemia: A Multicenter Analysis from the Extension-Myocardial Iron Overload in Thalassemia Network

ISTH Academy, Faculty / Presenters, 407684

PB0509 Timing of Anticoagulants in Patients with Venous Thromboembolism after Recent Intracerebral Hemorrhage

ISTH Academy, Faculty / Presenters, 407685

PB0504 Clinical Usefulness of Risk Tools Predicting Recurrence of Unprovoked Venous Thromboembolism: A Systematic Review and Meta-Analysis

ISTH Academy, Faculty / Presenters, 407686

PB0505 Outcomes of Patients with Pulmonary Embolism Admitted to the Intensive Care Unit

ISTH Academy, Faculty / Presenters, 407687

PB0495 Apixaban Use in Abdominal Transplant Recipients at a Large Academic Medical Center

ISTH Academy, Faculty / Presenters, 407688

PB0496 Bleeding Risk with Long-Term Fondaparinux Use for Secondary Prevention of Thromboembolism at a Tertiary Centre in the UK: A Retrospective Observational Audit

ISTH Academy, Faculty / Presenters, 407689

PB0497 Care Bundle for Management of Venous Thromboembolism: A Systematic Review

ISTH Academy, Faculty / Presenters, 407690

PB0498 Clinical Outcomes of Iliofemoral DVTs Associated with May-Thurner Syndrome

ISTH Academy, Faculty / Presenters, 407691

PB0499 Do All Patients with Acute Pulmonary Embolism Classified as Low Risk Based on a Simplified PESI are Truly at Low Risk of In-Hospital Adverse Outcomes?

ISTH Academy, Faculty / Presenters, 407692

PB0500 Edoxaban for Acute and Long-Term Treatment of Venous Thromboembolism: Real-Life Data from a Single Center Cohort Study

ISTH Academy, Faculty / Presenters, 407693

PB0501 Effect of High-Normal Renal Function on Apixaban Plasma Levels for Venous Thromboembolism Treatment in Obese Patients with BMI>40 Kg/M2

ISTH Academy, Faculty / Presenters, 407694

PB0502 Factors Associated with Outpatient Treatment among Patients with Low-Risk Pulmonary Embolism

ISTH Academy, Faculty / Presenters, 407695

PB0503 Patient Perspectives on Barriers and Facilitators to Warfarin Patient Self-Management in the US Healthcare System

ISTH Academy, Faculty / Presenters, 407696

PB0494 Defining the Optimal Cutoff Value of Gen-5 High-Sensitivity Troponin for the Risk-Stratification of Patients with Acute Pulmonary Embolism

ISTH Academy, Faculty / Presenters, 407697

PB0489 Different Oral Anticoagulants Have Distinct Interference in Thrombin Generation Parameters

ISTH Academy, Faculty / Presenters, 407698

PB0490 Does a Machine Learning Based Algorithm Improve Dosing of Vitamin K Antagonists Compared to Current Decision Support Programs?

ISTH Academy, Faculty / Presenters, 407699

PB0491 Patients from Different Settings Receiving Unfractionated Heparin (DEXHEP Study): Impact of PF4 on Anti-Xa Levels

ISTH Academy, Faculty / Presenters, 407700

PB0492 Review of Edoxaban Plasma Concentrations from King's College Hospital, UK

ISTH Academy, Faculty / Presenters, 407701

PB0493 Top 10 VTE Research Priorities of Patients and Clinicians: Clot Top 10 Priorities Results

ISTH Academy, Faculty / Presenters, 407702

PB0486 Effect of Age on Risk for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis

ISTH Academy, Faculty / Presenters, 407703

PB0487 Homozygous AT Deficiency Type II Heparin-Binding Site (HBS) - False Increase in the Level of Antithrombin Depending on the Concentration of the Direct Inhibitor of Activated Factor X (Apixaban)

ISTH Academy, Faculty / Presenters, 407704

PB0488 Interaction between Rivaroxaban, Apixaban or Edoxaban with Tacrolimus in Lung Transplant Recipients with Venous Thromboembolism (VTE)

ISTH Academy, Faculty / Presenters, 407705

PB0481 A Randomized Controlled Trial to Evaluate the Efficacy of an 8-Week Standardized Exercise Training Program for Preventing Post- Pulmonary Embolism Syndrome: Rationale & Design of the PE@HOME Study

ISTH Academy, Faculty / Presenters, 407706

PB0482 Clinical and Genetic-Based Refinement of the Warfarin Dose

ISTH Academy, Faculty / Presenters, 407707

PB0483 Enoxaparin for the Long-Term Therapy of Venous Thromboembolism in Patients with Cancer and Renal Insufficiency. The RIETECAT-RI Study

ISTH Academy, Faculty / Presenters, 407708

PB0474 Anticoagulant Management and Outcomes in Non-Traumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism

ISTH Academy, Faculty / Presenters, 407709

PB0485 Use of DOACs in the Management of Upper Extremity Deep Venous Thrombosis: A Systematic Review

ISTH Academy, Faculty / Presenters, 407710

PB0475 Empowering Patient Ambassadors to Champion Research Outcomes that are a Priority for People Who Have Lived Experience with Venous Thromboembolism (VTE)

ISTH Academy, Faculty / Presenters, 407711

PB0476 Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genetic Variants

ISTH Academy, Faculty / Presenters, 407712

PB0477 Safety and Efficacy of Direct Oral Anticoagulants in Patients with Chronic Thromboembolic Pulmonary Hypertension

ISTH Academy, Faculty / Presenters, 407713

PB0478 Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the MAC Project

ISTH Academy, Faculty / Presenters, 407714

PB0479 The ABC-Bleeding Score for Prediction of On-Treatment Clinically Relevant Bleeding in Patients with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study

ISTH Academy, Faculty / Presenters, 407715

PB0480 Tinzaparin Safety in Patients with Severe Renal Impairment

ISTH Academy, Faculty / Presenters, 407716

PB0467 Antithrombin Levels after Acute Pulmonary Embolism: The Thromboembolism Heparinization and Antithrombin Observational Study (THANOS-1)

ISTH Academy, Faculty / Presenters, 407717

PB0468 Direct Oral Anticoagulant Therapy in Adolescent Venous Thromboembolism: A Systematic Review

ISTH Academy, Faculty / Presenters, 407718

PB0469 Frequency of INR Monitoring and Their Impact on INR Control during the COVID-19 Pandemic

ISTH Academy, Faculty / Presenters, 407719

PB0470 Platelet Spreading/Clot Contraction Phenotype Correlates with Venous Thrombosis Response in Integrin Signaling Mutant Mice

ISTH Academy, Faculty / Presenters, 407720

PB0471 Thrombelastography-Defined Duration of Hypercoagulability Following Primary Total Hip and Total Knee Arthroplasty

ISTH Academy, Faculty / Presenters, 407721

PB0472 Use of Andexanet Alfa and 4-factor Prothrombin Complex Concentrate for Reversal Therapy in Severe Hemorrhage: A Single-Centre Cohort Study

ISTH Academy, Faculty / Presenters, 407722

PB0473 VTE Outcomes in Patients Treated with Direct Oral Anticoagulants and Concurrent Antiepileptic Drugs: Data from the START2 and the RIETE

ISTH Academy, Faculty / Presenters, 407723

PB0460 Clinical Effectiveness and Safety of Edoxaban in Obese Patients - Results of the Prospective Dresden NOAC Registry (NCT01588119)

ISTH Academy, Faculty / Presenters, 407724

PB0461 Crucial Role of CX3CR1-CX3CL1 Axis in Thrombus Resolution in Murine DVT Model

ISTH Academy, Faculty / Presenters, 407725

PB0462 Early Discharge and Home Treatment of Patients with Acute Pulmonary Embolism in the Tertiary Care Setting

ISTH Academy, Faculty / Presenters, 407726

PB0463 Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project

ISTH Academy, Faculty / Presenters, 407727

PB0464 Smaller Nadroparin Dose Reductions Required for Patients with Renal Impairment: A Multicenter Study

ISTH Academy, Faculty / Presenters, 407728